Echolight obtains FDA Clereance.

It’s a great pleasure to announce that Echolight has received the 510(K) approval from the FDA –  U.S. Food and Drug Administration, the governing body that regulates the trade of medical devices within the US market, for its EchoS system and the final authorization to start marketing and selling it since last November.

This new important achievement and recognition obtained internationally, is a fundamental element for the diffusion of the innovative R.E.M.S. technology (Radiofrequency Echographic Multi Spectrometry) worldwide, which thanks to its high levels of precision recognized by the scientific community, in combination with the complete absence of ionizing radiation and proven ease of use, will allow EchoS to be effectively used for the early diagnosis of the osteoporosis and bone health assessment in primary care.

EchoS, entirely developed in Italy, and already marketed in over 30 countries, provides the medical community with the next generation of bone densitometry, capable of evaluating the bone status to prevent fractures and constantly monitor the parameters for disease analysis, aimed at raising the quality of life worldwide.

Remsify your clinic

Remsify your clinic

The first R.E.M.S. Clinic  We are pleased to announce the opening of the first diagnostic center in Romania entirely dedicated to R.E.M.S technology. At the “Osteodensys” center in Bucharest, bone densitometries are exclusively performed by the R.E.M.S. technology...

leggi tutto
Echolight in France

Echolight in France

Echolight has always benefited from the highly professional and competent partners for the marketing of the innovative EchoS bone densitometer all over the world, and recently also in France. The high level of innovation achieved through the use of R.E.M.S. technology...

leggi tutto
Echolight in Russia

Echolight in Russia

Echolight secured the Russian certification. We are proud to announce that we have obtained the certification for the marketing of our devices in Russia. A further recognition obtained in these days by Roszdravnadzor (Federal Service for Surveillance in Healthcare),...

leggi tutto
Share This